Fig. 4

Frequencies of polymorphonuclear cells in the study groups. The Fig. 4 shows the frequencies of total granulocytes (4A), eosinophils (4B) and neutrophils (4C) in the control subjects (n=20), PLHIV-1 with therapeutic success (n=40) and PLHIV-1 with therapeutic failure (n=50). Healthy control subjects and PLHIV-1 under ARV treatment for at least 6 months were recruited at the University hospital of Abomey-Calavi/Sô-Ava between October 2021 and April 2022. Data were shown as box plots representing medians (with 25th and 75th percentiles). The statistical differences were determined using the nonparametric Kruskal-Wallis test with Dunn’s multiple comparisons. Differences were considered significant when p values are less than 0.05